Would you have Bronchitis chronic when you have Multiple sclerosis?
Summary: Bronchitis chronic is found among people with Multiple sclerosis, especially people who are female, 30-39 old, also have Depression, and take medication Avonex.
We study 30 people who have Bronchitis chronic and Multiple sclerosis from FDA and social media. Find out below who they are, other conditions they have and drugs they take.
You are not alone: join a support group for people who have Multiple sclerosis and Bronchitis chronic >>>
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) can be treated by Copaxone, Tysabri, Avonex, Rebif, Betaseron, Baclofen. (latest reports from 224,273 Multiple Sclerosis patients)
Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic) has been reported by people with osteoporosis, rheumatoid arthritis, osteopenia, high blood pressure, high blood cholesterol. (latest reports from 3,041 Bronchitis chronic patients)
On Feb, 27, 2015: 30 people who have multiple sclerosis and Bronchitis Chronic are studied.
Gender of people who have multiple sclerosis and experienced Bronchitis chronic * :
|Bronchitis chronic||97.30%||2.70% |
Age of people who have multiple sclerosis and experienced Bronchitis chronic * :
|Bronchitis chronic||0.00%||0.00%||0.00%||6.06%||3.03%||24.24%||51.52%||15.15% |
Severity of the symptom * :
Top co-existing conditions for these people * :
- Depression (5 people, 16.67%)
- Insomnia (4 people, 13.33%)
- Type 2 diabetes mellitus (4 people, 13.33%)
- Hormone replacement therapy (4 people, 13.33%)
- Hypothyroidism (4 people, 13.33%)
- Fibromyalgia (4 people, 13.33%)
- Gastrooesophageal reflux disease (4 people, 13.33%)
- Hypertension (4 people, 13.33%)
- Headache (4 people, 13.33%)
- Hypersensitivity (4 people, 13.33%)
Most common drugs used by these people * :
- Avonex (19 people, 63.33%)
- Tysabri (11 people, 36.67%)
- Baclofen (8 people, 26.67%)
- Copaxone (5 people, 16.67%)
- Omeprazole (4 people, 13.33%)
- Gilenya (4 people, 13.33%)
- Dulcolax (4 people, 13.33%)
- Atenolol (4 people, 13.33%)
- Estradiol (4 people, 13.33%)
- Levothyroxine sodium (4 people, 13.33%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Get connected: join our support group of multiple sclerosis and bronchitis chronic on
Do you have Multiple Sclerosis and Bronchitis Chronic?
You are not alone! Join a support group on :
- support group for people who have Bronchitis Chronic and Multiple sclerosis
- support group for people who have Multiple sclerosis
- support group for people who have Bronchitis Chronic
Could your drug cause:
Other conditions that could cause:
Recent Multiple Sclerosis related drug comparison:
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.